June 2019 – Successful in-vivo experiment in May 2019. Two Cor/log Probe 1P were implanted into a freely moving pig. Zero drift of the pressure baseline over 29 days. Measurement of S1 and S2 heart sounds due to high frequency resolution of the probe. This can be used to identify the a- and v-wave of the central venous pressure which can be used to diagnose tricuspid valve regurgitation. Continuous data transfer during this time to Cor/log Connect and Cor/log App.

May 2019 – We will be presenting our Cor/log System at the Hamburg Heart Days 2019 from 17 to 18 May. You can visit us at booth 22 in the tent. We are excited to talk to you about monitoring of structural heart diseases in the right heart.

January 2019 – After much work and effort of our team, we are proud to present the finalized system for Cor/log Probe 1P.

Take a look at our short presentation of the system and its applications. Cor/log Probe 1P will be soon available for the European market.

You can meet us on the Annual Congress of the German Society of Cardiac and Thoracic Surgeons midst of February 2019 in Wiesbaden.

September 2018 – emka MEDICAL has successfully passed its recertification audit according to ISO 13485:2016. You can find our new certificates here.

September 2017 – The company name has been changed from CGS Sensors GmbH to emka MEDICAL GmbH since 18. September 2017.

September 2016 – A BayMED grant of 250k€ from the Free State of Bavaria has been awarded to develop the Cor/log Probe 1P with specific indications for use in jugular vein pressure monitoring of heart failure patients.

February 2016 – The joint project CorLog proposed by our sister company MI Medical Innovation together with our French partner, emka TECHNOLOGIES, got granted with Horizon 2020 Seal of Excellence, issued by the European Commission on 8 February 2016.